Efficacy of conventional‐dose cytarabine, idarubicin and thioguanine versus intermediate‐dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long‐term results of the prospective randomized nationwide <scp>AML</scp> ‐2003 study by the Finnish Leukemia Group-Reference-Cited by-同舟云学术

Efficacy of conventional‐dose cytarabine, idarubicin and thioguanine versus intermediate‐dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long‐term results of the prospective randomized nationwide AML ‐2003 study by the Finnish Leukemia Group

Published:2022-06-14 Issue:3 Volume:109 Page:257-270
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:European J of Haematology

Author:

Kolonen Aarne¹,Sinisalo Marjatta¹,Huhtala Heini²,Rimpiläinen Johanna¹,Rintala Hannele¹,Sankelo Marja¹,Koivunen Elli¹,Silvennoinen Raija¹^ORCID,Räty Riikka³,Ruutu Tapani³,Volin Liisa³,Porkka Kimmo³,Jantunen Esa⁴,Nousiainen Tapio⁴,Kuittinen Taru⁴,Penttilä Karri⁴,Pyörälä Marja⁴,Säily Marjaana⁵,Koistinen Pirjo⁵,Kauppila Marjut⁶,Itälä‐Remes Maija⁶,Ollikainen Hanna⁷,Rauhala Auvo⁸⁹,Kairisto Veli¹⁰,Pelliniemi Tarja‐Terttu¹¹,Elonen Erkki³,

Affiliation:

1. Department of Internal Medicine Tampere University Hospital Tampere Finland

2. Faculty of Social Sciences Tampere University Tampere Finland

3. Department of Hematology Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki Helsinki Finland

4. Department of Medicine Kuopio University Hospital Kuopio Finland

5. Department of Medicine Oulu University Hospital Oulu Finland

6. Stem Cell Transplantation Unit Turku University Hospital Turku Finland

7. Department of Medicine Satakunta Central Hospital Pori Finland

8. The Faculty of Education and Welfare Studies, Department of Health Sciences Åbo Akademi University Vaasa Finland

9. Client and Patient Safety Center Vaasa Central Hospital Vaasa Finland

10. Laboratory of Molecular Haematology and Pathology Turku University Central Hospital Turku Finland

11. Department of Clinical Chemistry University of Turku, Finland and Fimlab Laboratories Ltd Tampere Finland